Unknown

Dataset Information

0

BNT162b2 and ChAdOx1 nCoV-19 Vaccine Effectiveness against Death from the Delta Variant.

ABSTRACT:

SUBMITTER: Sheikh A 

PROVIDER: S-EPMC8552534 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Increased neutralization of SARS-CoV-2 Delta variant after heterologous ChAdOx1 nCoV-19/BNT162b2 versus homologous BNT162b2 vaccination.
| S-EPMC8730691 | biostudies-literature
Unknown Effectiveness of BNT162b2 Vaccine against Delta Variant in Adolescents.
| S-EPMC8552532 | biostudies-literature
Unknown Neutralization of the SARS-CoV-2 Delta variant after heterologous and homologous BNT162b2 or ChAdOx1 nCoV-19 vaccination.
| S-EPMC8381713 | biostudies-literature
Unknown Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant.
| S-EPMC7993410 | biostudies-literature
Unknown Heterologous prime-boost vaccination with ChAdOx1 nCoV-19 and BNT162b2.
| S-EPMC8321428 | biostudies-literature
Unknown Effectiveness of mRNA-BNT162b2, mRNA-1273, and ChAdOx1 nCoV-19 vaccines against COVID-19 in healthcare workers: an observational study using surveillance data.
| S-EPMC8275842 | biostudies-literature
Unknown Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination.
| S-EPMC8440184 | biostudies-literature
Unknown Blood clots and bleeding events following BNT162b2 and ChAdOx1 nCoV-19 vaccine: An analysis of European data.
| S-EPMC8220408 | biostudies-literature
Unknown Adverse Reactions Following the First Dose of ChAdOx1 nCoV-19 Vaccine and BNT162b2 Vaccine for Healthcare Workers in South Korea.
| S-EPMC8093607 | biostudies-literature
Unknown Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa.
| S-EPMC8757569 | biostudies-literature